Joshua Silverman, Director at MyMD Pharmaceuticals, Inc. (MYMD), bought 15,000 shares at $7.09 ($103K) on 2021-11-24, disclosed to the SEC on 2021-11-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.30 | 6,734 | $42K | 41.1% |
| 2 | $7.09 | 3,266 | $23K | 22.4% |
| 3 | $7.55 | 5,000 | $38K | 36.5% |
| Total | $6.89 avg | 15,000 | $103K | 100% |
| Filing → |
| AYRO | SELL | 2023-05-05 | $6K | — | Filing → |
| AYRO | SELL | 2023-02-03 | $5K | — | Filing → |
| SNPX | SELL | 2022-12-20 | $22K | — | Filing → |